Cirevetmab Biosimilar

REQUEST MORE INFO
Catalogue No: abx832306
Price: US$478.50
(Size: 100 µg)

Orders to United States ship from United States

Reviews: There are no reviews for this product.<br>Leave a review for us and help us better the community and our services.
(There are no reviews for this product.
Leave a review for us and help us better the community and our services.)
Cirevetmab Biosimilar

Click on the image to see the image legend

Available Options

* Size:




Add to Cart Buy It Now GET A QUOTE

Documents

Datasheet SDS
Cirevetmab is a Caninized monoclonal antibody biosimilar expressed in Mammalian cells, targeting Transforming Growth Factor Beta-1 Proprotein (TGFB1), for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.

Target Transforming Growth Factor Beta-1 Proprotein (TGFB1)
Clonality Monoclonal
Reactivity Dog
Expression Recombinant
Host Dog
Isotype IgG2 Kappa
Form Liquid
Purity > 95% (SDS-PAGE)
Purification Purified from cell culture supernatant by protein A/G chromatography.
Storage Store at 4°C for up to 2 weeks. Aliquot and store at -20°C for long term storage. Avoid repeated freeze/thaw cycles.
Shelf Life 12 months.
Buffer 0.01 M PBS, pH 7.4.
CAS Number 2473240-98-9
Availability Shipped within 5-12 working days.
Note THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
Research Articles on Transforming Growth Factor Beta-1 Proprotein (TGFB1)


Write a review

Continue
Tags:
(Click to show)